Anna Hüsing‐Kabar
Impact in
- Hepatology top 5%
- Liver Disease and Transplantation
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments
Papers in
- Hepatology 12
- Liver Disease and Transplantation 9
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Liver Diseases and Immunity 3
- Epidemiology 10
- Liver Disease Diagnosis and Treatment 8
- Co-authors
- Hartmut Schmidt (18 shared papers)Iyad Kabar (14 shared papers)Miriam Maschmeier (6 shared papers)Christian Wilms (6 shared papers)Gerold Thölking (4 shared papers)Richard Vollenberg (3 shared papers)Susanne Beckebaum (2 shared papers)Phil‐Robin Tepasse (3 shared papers)
- Journals
- United European Gastroenterology Journal (3 papers)Nutrients (2 papers)Canadian Journal of Gastroenterology and Hepatology (2 papers)Frontiers in Aging Neuroscience (1 paper)Orphanet Journal of Rare Diseases (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Anna Hüsing‐Kabar
23 papers receiving 440 citations
Peers
Comparison fields: 5 of 64
- Hepatology 254
- Transplantation 35
- Pharmacology 48
- Epidemiology 174
- Surgery 197
Countries citing papers authored by Anna Hüsing‐Kabar
This map shows the geographic impact of Anna Hüsing‐Kabar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Hüsing‐Kabar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Hüsing‐Kabar more than expected).
Fields of papers citing papers by Anna Hüsing‐Kabar
This network shows the impact of papers produced by Anna Hüsing‐Kabar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Hüsing‐Kabar. The network helps show where Anna Hüsing‐Kabar may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Hüsing‐Kabar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 116 | |
| 2 | 2018 | 49 | |
| 3 | 2021 | 48 | |
| 4 | 2017 | 45 | |
| 5 | 2017 | 31 | |
| 6 | 2022 | 26 | |
| 7 | 2017 | 22 | |
| 8 | 2019 | 17 | |
| 9 | 2017 | 17 | |
| 10 | 2018 | 13 | |
| 11 | 2020 | 11 | |
| 12 | 2018 | 8 | |
| 13 | 2021 | 8 | |
| 14 | 2022 | 8 | |
| 15 | 2021 | 7 | |
| 16 | 2019 | 7 | |
| 17 | 2017 | 5 | |
| 18 | 2019 | 3 | |
| 19 | 2020 | 2 | |
| 20 | 2024 | 2 |
About Anna Hüsing‐Kabar
Anna Hüsing‐Kabar is a scholar working on Hepatology, Epidemiology, Surgery, Nutrition and Dietetics and Neurology, having authored 23 papers that have together received 448 indexed citations. Recurring topics across this work include Liver Disease and Transplantation (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Organ Transplantation Techniques and Outcomes (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Long-Term Effects of COVID-19 (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), COVID-19 Clinical Research Studies (3 papers) and Liver Diseases and Immunity (3 papers). The work is most often cited by research in Hepatology (254 citations), Transplantation (35 citations), Pharmacology (48 citations), Epidemiology (174 citations) and Surgery (197 citations). Anna Hüsing‐Kabar has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Hartmut Schmidt, Iyad Kabar, Miriam Maschmeier, Christian Wilms, Gerold Thölking, Richard Vollenberg, Susanne Beckebaum, Phil‐Robin Tepasse, Vito R. Cicinnati and Vicente Arroyo. Their work appears in journals such as United European Gastroenterology Journal, Nutrients, Canadian Journal of Gastroenterology and Hepatology, Frontiers in Aging Neuroscience and Orphanet Journal of Rare Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.